News

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...
In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...
At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...
The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...
A Cell Metabolism study reveals that GIPR signaling in oligodendrocytes enhances brain access and weight-loss efficacy of GLP ...
Oikos Fusion offers a nutrient-dense dairy drink designed to support muscle mass and digestive health during weight loss ...
As other pharmas drop next-gen obesity assets, Eli Lilly’s experimental oral GLP-1 has prompted weight loss up to ...